Inclusion criteria
Participant has reached his or her 55th birthday at the time of informed consent Participant provides written informed consent Participant is capable of complying with study procedures Participant is capable of communicating with study personnel Participant understands and speaks English Participant has at least an 8th Grade education Participant has no significant hepatic or renal disease as defined by previous medical history and lab results HC group Participant has a low probability of being currently positive for AD as determined by a Mini Mental State Examination (MMSE ≥28) AD group Participant has a high probability of being currently positive for AD that is determined by a Mini Mental State Examination (MMSE <24) Exclusion Criteria Female participant is pregnant or nursing Participant has prior history of stroke or other condition of the head or neck that, in the Investigators opinion, might affect circulation to the head or image interpretation Participant has other neurodegenerative disease that is associated with cognitive impairment or dementia Participant has a medical condition that might be associated with elevated amyloid levels, such as amyloid angiopathy, familial amyloidosis, chronic kidney dialysis, Down's syndrome Participant has a history of significant cerebrovascular disease Participant has previously received [F-18]T807 at any time Participant has been involved in an investigative, radioactive research procedure within the past 14 days Participant has any other condition or personal circumstance that, in the judgment of the Investigator, might interfere with the collection of complete data or data quality Participant has a history in the last five years of significant prescription or non-prescription drug or alcohol abuse, including but not limited to marijuana, cocaine, heroin or derivatives * Correspondence to: Hartmuth C. Kolb, Siemens Molecular 
